Humana (HUM) Receivables (2009 - 2026)

Humana (HUM) has 18 years of Receivables data on file, last reported at $5.2 billion in Q1 2026.

• On a quarterly basis, Receivables rose 17.02% year-over-year to $5.2 billion in Q1 2026; TTM through Mar 2026 was $5.2 billion, a 17.02% increase from a year earlier, with the FY2025 full-year figure at $3.3 billion, up 20.93% from the prior year.
• Receivables for Q1 2026 stood at $5.2 billion, up from $3.3 billion in the prior quarter.
• Over the last five years, Receivables for HUM reached as high as $5.2 billion in Q1 2026 and fell as low as $357.0 million in Q4 2023.
• Historically, Receivables has averaged $2.8 billion across 5 years, with a median of $3.1 billion in 2023.
• Across the five-year window, Receivables plunged 82.98% in 2023 and jumped 808.33% in 2025, its largest moves.
• Year by year, Receivables stood at $2.1 billion in 2022, then plunged by 82.98% to $357.0 million in 2023, then advanced by 0.84% to $360.0 million in 2024, then soared by 808.33% to $3.3 billion in 2025, then soared by 59.57% to $5.2 billion in 2026.
• Per Business Quant data, the three most recent Receivables figures were $5.2 billion in Q1 2026, $3.3 billion in Q4 2025, and $2.7 billion in Q3 2025.